Ex vivo culture with human brain endothelial cells increases the SCID-repopulating capacity of adult human bone marrow

Blood

Volumn 100, Issue 13, 2002, Pages 4433-4439

  Chute, John P ^a,b,c,d,e   Saini, Abha A ^a,b,c,d,e   Chute, Dennis J ^a,b,c,d,e   Wells, Mark R ^a,b,c,d,e   Clark, William B ^a,b,c,d,e   Harlan, David M ^a,b,c,d,e   Park, Jenny ^a,b,c,d,e   Stull, Margaret K ^a,b,c,d,e   Civin, Curt ^a,b,c,d,e   Davis, Thomas A ^a,b,c,d,e  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c OFFICE OF THE CHIEF MEDICAL EXAMINER   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e Large Scale Biology Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; BONE MARROW CELL; BRAIN CELL; CELL ACTIVITY; CELL ASSAY; CELL CONTACT; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL POPULATION; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DIABETES MELLITUS; DILUTION; ENDOTHELIUM CELL; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LYMPHOID CELL; MOUSE; MOUSE STRAIN; NONHUMAN; OBESITY; PRIORITY JOURNAL; TIME;

EID: 0037114623     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-04-1238     Document Type: Article

References (55)

1. Gan OI, Murdoch B, Larochelle A, Dick JE. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells. Blood. 1997;90:641-650.
2. Nolta JA, Smorgorzewska EM, Kohn DB. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood. 1995;86:101-110.
3. + cells in non-obese diabetic/severe combined immunedeficient mice. Blood. 1998;92:2641-2649.
4. + cells. Exp Hematol. 1998;26:53-62.
5. + blood progenitor cells. Stem Cells. 1999;17:152-161.
6. Williams D. Ex vivo expansion of hematopoietic stem and progenitor cells: Robbing Peter to pay Paul? Blood. 1993;81:3169-3177.
7. Larochelle A, Vormoor J, Hanenberg H, et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nat Med. 1996;2:1329-1337.
8. Bhatia M, Wang J, Kapp U, Bonnet D, Dick J. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A. 1997;94:5320-5325.
9. Bhatia M, Bonnet D, Murdoch B, Gan O, Dick JE. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med. 1998;4:1038-1045.
10. Cashman J, Lapidot T, Wang J, et al. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood. 1997;89:4307-4316.
11. Holyoake T, Nicolini F, Eaves C. Functional differences between transplantable human hematopoiatic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol. 1999;27:1418-1427.
12. Wang JC, Doedens M, Dick JE. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood. 1997;89:3919-3924.
13. + side population (SP) phenotype. J Clin Invest. 2001;108:1071-1077.
14. Aiuti A, Friedrich C, Sleff CA, Gutierrez-Ramos JC. Identification of distinct elements of the stromal microenvironment that control human hematopoietic stem/progenitor cell growth and differentiation. Exp Hematol. 1998;26:143-157.
15. Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of hematopoietic stem cells in vitro. J Cell Physiol. 1977;91:335-344.
16. Dorshkind K. Regulation of hemopoiesis by bone marrow stromal cells and their products. Annu Rev Immunol. 1990;8:111-137.
17. Verfaillie CM. Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long term in vitro hematopoiesis. Blood. 1992;79:2821-2826.
18. Rafii S, Shapiro F, Rimarachin J, et al. Isolation and characterization of human bone marrow microvascular endothelial cells: Hematopoietic progenitor cell adhesion. Blood. 1994;84:10-19.
19. Rafii S, Shapiro F, Pettengell R, et al. Human bone marrow microvascular endothelial cells support long term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood. 1995;86:3353-3363.
20. Lu LS, Wang SJ, Auerbach R. In vitro and in vivo differentiation into B cells, T cells, and myeloid cells of primitive yolk sac hematopoietic precursor cells expanded > 100-fold by co-culture with a clonal yolk sac endothelial cell line. Proc Natl Acad Sci U S A. 1996;93:14782-14787.
21. Davis TA, Robinson DH, Lee KP, Kessler SW. Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replating potential: Requirement for cell-to-cell interactions and colony-stimulating factors. Blood. 1995;85:1751-1761.
22. + cells cultured in stroma-free versus porcine microvascular endothelial cell cultures. Exp Hematol. 1999;27;370-379.
23. Brandt JE, Galy AH, Luens KM, et al. Bone marrow repopulation by human marrow stem cells after long-term expansion culture on a porcine endothelial cell line, Exp Hematol. 1998;26:950-961.
24. Brandt JE, Bartholomew A, Fortman JD, et al. Ex vivo expansion of autologous bone marrow stem cells with porcine microvascular endothelial cells results in a graft capable of rescuing lethally irradiated baboons. Blood. 1999;94:106-113.
25. + cord blood cells after ex vivo expansion: Evidence for the amplification and self-renewal of repopulating stem cells. Blood. 1999;93:3736-3749.
26. Bhatia M, Bonnet D, Kapp U, Wang J, Murdoch B, Dick J. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med. 1997;186:619-624.
27. Ueda T, Tsuji K, Yoshino H, et al. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest. 2000;105:1013-1021.
28. Conneally E, Cashman J, Petzer A, Eaves C. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Nail Acad Sci U S A. 1997;94:9636-9641.
29. Jordan CT, Yamasaki G, Minamoto D. High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations. Exp Hematol. 1996;24:1347-1355.
30. Schulz LD, Schweitzer P, Christianson S, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 1995;154:180-191.
31. + cells in bone marrow by flow cytometry. J Hematother. 1993;2:305-313.
32. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies, I: Data analysis. J Immunol. 1981;126:1614-1619.
33. Horwitz M. Uses and growth of hematopoietic cell transplantation. In: Thomas ED, Blume KG, Forman SJ, eds. Hematopoietic Cell Transplantation. 2nd Ed. Malden, MA: Oxford University Press; 1998:12-18.
34. Ciancio G, Garcia-Morales R, Mathew J, et al. Donor bone marrow infusions are tolerogenic in human renal transplantation. Transplant Proc. 2001;33:1295-1296.
35. Orlic D, Girard L, Jordan C, et al. The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc Natl Acad Sci U S A. 1996;93:11097-11102.
36. Chute J, Salni A, Wells M, et al. Preincubation with endothelial cell monolayers increases gene transfer efficiency Into human bone marrow CD34+CD38- progenitor cells. Hum Gene Ther. 2000;11:2515-2528.
37. Van der Sluijs JP, van den Bos C, Baert MR, van Beurden CA, Ploemacher RE. Loss of long term repopulating ability in long-term bone marrow culture. Leukemia. 1993;7:725-732.
38. Dorrell C, Gan O, Pereira D, Hawley R, Dick J. Expansion of human cord blood CD34+CD38-cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: Dissociation of SRC phenotype and function. Blood. 2000;95:102-110.
39. Mehta K, McQueen T, Manshouri T, Andreef M, Collins S, Albitar M. Involvement of retinoic acid receptor-alpha-mediated signaling pathway in induction of CD34 cell-surface antigen. Blood. 1997;89:3607-3614.
40. + cord blood cells is linked to apoptosis after growth factor withdrawal. Exp Hematol, 2000;28:907-915.
41. Glimm H, Oh I-H, Eaves C. Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G2/M transit and do not reenter GO. Blood. 2000;96:4185-4193.
42. Peters S, Kittler E, Ramshaw H, Quesenberry P. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood. 1996;87:30-37.
43. Van Hennick P, de Koning A, Ploemacher R. Seeding efficiency of primitive human hematopoietic cells in non-obese diabetic/severe combined immune deficiency mice: Implications for stem cell frequency assessment. Blood. 1999;94:3055-3061.
44. Wagers A, Allsopp R, Weissman I. Changes in integrin expression are associated with altered homing properties of Lin(-/Io)Thy1.1/Io)Sca-1(+)c-kit(+) hematopoletic stem cells following mobilization by cyclophosphamide/granulocyte colony-stimulating factor. Exp Hematol. 2002;30:176-185.
45. Berrios V, Dooner G, Nowakowski G, et al. The molecular basis for the cytokine-induced defect in homing and engraftment of hematopoietic stem cells. Exp Hematol. 2001:29:1326-1335.
46. Peled A, Petit I, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 1999;283:845-848.
47. Varnum-Finney B, Xu L, Brashem-Steln C, et al. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch 1 signaling. Nat Med. 2000;6:1278-1281.
48. Bonnet D, Bhatia M, Wang J, Kapp U, Dick J. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoletic cells transplanted at limiting doses into NOD/SCID mice. Bone Marrow Transplant. 1999;23:203-209.
49. Verstegen M, van Hennik P, Terpstra W, et al. Transplantation of human umbilical cord blood cedis in macrophage-depleted SCID mice: Evidence for accessory cell involvement in expansion of immature CD34+CD38- cells. Blood. 1998;91:1966-1976.
50. Breems D, Blokland E, Siebel K, Mayen A, Engels L, Ploemacher R. Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells. Blood. 1998;91:111-117.
51. Dao M, Hashino K, Kato I, Nolta J. Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells. Blood. 1998;92:4612-4621.
52. Thomson B, Robertson K, Gowan D, et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood. 2000;96:2703-2711.
53. Hogan C, Schpall E, Keller G, et al. Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice. Proc Natl Acad Sci U S A. 2002;99:413-418.
54. Lewis I, AImeida-Porada G, Du J, et al. Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system, Blood. 2001;97:3441-3449.
55. Glimm H, Eaves C. Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture. Blood. 1999;94:2161-2168.